Author - JenniferLaude

Low-pressure hyperbaric oxygen treatment and physical exercise in women with fibromyalgia: randomized clinical trial

There are anecdotal reports of fibromyalgia patients experiencing relief from pain and fatigue following a course of low-pressure HBOT; researchers (June, 2020) have recently provided empirical evidence to support such accounts. Izquierdo-Alventosa et. al performed a small randomized clinical trial investigating the impact of low-pressure hyperbarics relative to physical exercise, and a no-treatment control. In general, the study found that both HBOT and exercise groups experienced improved pressure pain threshold, endurance and functional capacity, as well as physical performance....

Read more...

What has HBOT of Idaho seen low pressure HBOT (mHBOT) help?

We often get inquires about whether we have personally seen results using low pressure hyperbarics for various conditions. The following are examples of conditions we have seen significant improvement using mHBOT, and therapies that we felt complemented the positive results. Recent concussion - mHBOT 10 sessions - showed significant reduction in headaches and light sensitivity. Adjunctive therapies: CBG by PrimeMyBody was very helpful in reducing headache severity, B complex vitamin (Nutridyn), Omega3s, increased healthy fat intake. < 14-yr old traumatic brain...

Read more...

THERAPIES TO COMBINE WITH mHBOT TO ENHANCE EFFECTS:

"We had a stroke patient at IMI whose speech and walking improved significantly using a combination of nattokinase, PEMF, and mHBOT. I also had the pleasure of working with a child diagnosed with autism who did methyl-B12 shots before mHBOT; he showed remarkable improvements in language and self-control. Generally speaking, doing even a 30-minute mHBOT before IV tends to enhance effects of IV treatment. My favorite supplements to use with mHBOT are liposomal vitamin C, Acetyl-L-Carnitine, alpha-lipoic acid, and chlorella." - Dr. Jen. Therapies we...

Read more...

WHAT IS MILD HYPERBARIC OXYGEN THERAPY (m-HBOT)?

m-HBOT represents a lower pressurized chamber, generally under 1.5 ATA, and typically at 1.3 ATA. These lower atmospheric pressures (representing roughly only 10 feet below sea level) allow for greater safety, while still allowing for the delivery of much higher levels of oxygen into the tissues. The FDA has cleared m-HBOT as an approved treatment for those suffering from altitude sickness, where oxygen levels can become dangerously low at higher elevations — a condition that is life threatening. The extra...

Read more...